The transcription factor SOX11 has recently been identified as a diagnostic, prognostic and/or functional antigen in a variety of cancers including mantle cell lymphoma (MCL)[1-6], epithelial ovarian cancer (EOC)[7,8] and gliomas[9]. This evidence concerns the gene SOX11 and central nervous system cancer.